MedPath

A cohort study of Wubiefanchun oral liquid in the treatment of premature ovarian insufficiency

Not Applicable
Conditions
premature ovarian insufficiency
Registration Number
ITMCTR2200006411
Lead Sponsor
Jiangsu Province Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the diagnostic criteria of POI TCM and Western Medicine

Exclusion Criteria

1. Bilateral or unilateral oophorectomy
2. Combined with severe primary diseases such as acute infectious diseases, cardiovascular, renal, liver and hematopoietic systems.
3. Mental patients and or due to intellectual and behavioral disorders.
4. Allergic constitution or allergic to multiple drugs.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FSH;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath